These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 9420339)

  • 21. TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin-treated patients with familial hypercholesterolemia.
    Mohrschladt MF; van der Sman-de Beer F; Hofman MK; van der Krabben M; Westendorp RG; Smelt AH
    Eur J Hum Genet; 2005 Jul; 13(7):877-82. PubMed ID: 15856070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction.
    Fumeron F; Betoulle D; Luc G; Behague I; Ricard S; Poirier O; Jemaa R; Evans A; Arveiler D; Marques-Vidal P
    J Clin Invest; 1995 Sep; 96(3):1664-71. PubMed ID: 7657837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholesteryl ester transfer protein as a protective factor against vascular disease in hemodialysis patients.
    Kimura H; Miyazaki R; Suzuki S; Gejyo F; Yoshida H
    Am J Kidney Dis; 2001 Jul; 38(1):70-6. PubMed ID: 11431184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic implications of cholesteryl ester transfer protein inhibitors in hyperlipidemia and low high-density lipoprotein-cholesterolemia.
    Inazu A; Mabuchi H
    Curr Opin Investig Drugs; 2003 Mar; 4(3):291-7. PubMed ID: 12735230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between the cholesteryl ester transfer protein TaqI-detectable B polymorphism and low high-density lipoprotein cholesterol concentration in Saudis.
    Al-Daghri NM; Al-Attas O; Patel A; Belyaev ND; Bartlett WA; Jones AF; Kumar S; Bain SC
    Clin Sci (Lond); 2003 Oct; 105(4):467-72. PubMed ID: 12773093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association of HDL cholesterol concentration with the -629C>A CETP promoter polymorphism is not fully explained by its relationship with plasma cholesteryl ester transfer.
    Dullaart RP; Borggreve SE; Hillege HL; Dallinga-Thie GM
    Scand J Clin Lab Invest; 2008; 68(2):99-105. PubMed ID: 17852818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.
    Brousseau ME; O'Connor JJ; Ordovas JM; Collins D; Otvos JD; Massov T; McNamara JR; Rubins HB; Robins SJ; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1148-54. PubMed ID: 12117730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional interaction between -629C/A, -971G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study.
    Frisdal E; Klerkx AH; Le Goff W; Tanck MW; Lagarde JP; Jukema JW; Kastelein JJ; Chapman MJ; Guerin M
    Hum Mol Genet; 2005 Sep; 14(18):2607-18. PubMed ID: 16049032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphism of the cholesteryl ester transfer protein gene.
    Dullaart RP; van Tol A
    N Engl J Med; 1998 May; 338(22):1625-6. PubMed ID: 9606121
    [No Abstract]   [Full Text] [Related]  

  • 30. Association of plasma cholesteryl ester transfer protein activity and polymorphism with coronary artery disease extent in Tunisian type II diabetic patients.
    Chaaba R; Hammami S; Attia N; Smaoui M; Masmoudi AS; Mahjoub S; Ben Hamda K; Hammami M
    Clin Biochem; 2005 Apr; 38(4):373-8. PubMed ID: 15766738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency.
    Moriyama Y; Okamura T; Inazu A; Doi M; Iso H; Mouri Y; Ishikawa Y; Suzuki H; Iida M; Koizumi J; Mabuchi H; Komachi Y
    Prev Med; 1998; 27(5 Pt 1):659-67. PubMed ID: 9808796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HDL cholesterol and TaqIB cholesteryl ester transfer protein gene polymorphism in renal transplant recipients.
    Radeau T; Vohl MC; Houde I; Lachance JG; Noël R; Després JP; Douville P; Bergeron J
    Nephron; 2000 Apr; 84(4):333-41. PubMed ID: 10754410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of the cholesteryl ester transfer protein Taq1 B2B2 genotype with higher high-density lipoprotein cholesterol concentrations and lower risk of coronary artery disease in a Tunisian population.
    Rejeb J; Omezzine A; Rebhi L; Naffeti I; Kchok K; Belkahla R; Bel Hadjmbarek I; Ben Rejeb N; Nabli N; Boujelbene A; Ben Abdelaziz A; Boughzala E; Bouslama A
    Arch Cardiovasc Dis; 2008 Oct; 101(10):629-36. PubMed ID: 19056069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TaqIB and severity of coronary artery disease in the Turkish population: a pilot study.
    Kaman D; İlhan N; İlhan N; Akbulut M
    Bosn J Basic Med Sci; 2015 Feb; 15(1):9-13. PubMed ID: 25725138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men.
    Liu S; Schmitz C; Stampfer MJ; Sacks F; Hennekens CH; Lindpaintner K; Ridker PM
    Atherosclerosis; 2002 Apr; 161(2):469-74. PubMed ID: 11888533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A polymorphism of the cholesteryl ester transfer protein gene predicts cardiovascular events in non-smokers in the West of Scotland Coronary Prevention Study.
    Freeman DJ; Samani NJ; Wilson V; McMahon AD; Braund PS; Cheng S; Caslake MJ; Packard CJ; Gaffney D
    Eur Heart J; 2003 Oct; 24(20):1833-42. PubMed ID: 14563342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphism of the cholesteryl ester transfer protein gene.
    Goldstein MR
    N Engl J Med; 1998 May; 338(22):1624-5; author reply 1625-6. PubMed ID: 9606120
    [No Abstract]   [Full Text] [Related]  

  • 38. Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes.
    van Venrooij FV; Stolk RP; Banga JD; Sijmonsma TP; van Tol A; Erkelens DW; Dallinga-Thie GM;
    Diabetes Care; 2003 Apr; 26(4):1216-23. PubMed ID: 12663600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants.
    van Acker BA; Botma GJ; Zwinderman AH; Kuivenhoven JA; Dallinga-Thie GM; Sijbrands EJ; Boer JM; Seidell JC; Jukema JW; Kastelein JJ; Jansen H; Verhoeven AJ;
    Atherosclerosis; 2008 Sep; 200(1):161-7. PubMed ID: 18164013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes.
    Dullaart RP; Hoogenberg K; Riemens SC; Groener JE; van Tol A; Sluiter WJ; Stulp BK
    Diabetes; 1997 Dec; 46(12):2082-7. PubMed ID: 9392500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.